Examining how COVID-19 changed pulmonary procedures
Official title: The Impact of COVID-19 on Pulmonary Procedures: A Nationwide Survey
Run by M.D. Anderson Cancer Center · NCT05022446 · Data updated 2026-11-12
This study looks at how doctors who treat lung conditions changed their procedures and staffing during the COVID-19 pandemic to see what worked best.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | November 11, 2020 |
| Main results expected | February 2, 2027 |
| Study ends | February 2, 2027 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT05022446 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pulmonologists who are members of the American Association of Bronchology and Interventional Pulmonology or the American College of Chest Physicians.
✕Probably not a fit
Patients who are not pulmonologists or who do not belong to the specified professional organizations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the adaptations made by pulmonary procedural programs across the United States in response to the COVID-19 pandemic. It aims to assess changes in procedural practices, ambulatory operations, and provider staffing among pulmonologists. Participants will complete a survey that takes approximately 5-10 minutes, providing valuable insights into how these programs adjusted during the crisis. The findings may guide future practices and research efforts in pulmonary medicine during pandemics.
Why it matters
Potential benefit: If successful, this study could enhance the preparedness and response of pulmonary programs during future pandemics.
How similar studies have gone: While this study focuses on a specific adaptation to the COVID-19 pandemic, similar studies have shown success in assessing changes in medical practices during health crises.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP) * These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership Exclusion Criteria: None
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Bruce F Sabath, MD — M.D. Anderson Cancer Center
- Study coordinator: Jhankruti F Zaveri, MPH
- Email: jzaveri@mdanderson.org
- Phone: (713) 745-2645
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of COVID-19 on young cancer patients and survivors
This study is trying to see how the COVID-19 pandemic has affected the mental, physical, and social well-being of young cancer patients and survivors aged 18 to 39.
-
Video education to boost knowledge and interest in cancer clinical trials
Adults in the Detroit area will watch a short educational video to see if it increases their knowledge about and interest in cancer clinical trials.
-
Using alteplase to improve fluid drainage and breathlessness in patients with malignant pleural effusion
This study tests if the medication alteplase can help people with fluid buildup in the lungs feel better and breathe easier when regular drainage isn’t enough.
-
Using weighted blankets to reduce anxiety in cancer patients during infusions
This study is testing whether using weighted blankets can help reduce anxiety in cancer patients during their first infusion therapy.
-
Letermovir to prevent cytomegalovirus after pediatric stem cell transplant
This study will try giving letermovir to CMV-positive children and adolescents receiving allogeneic stem cell transplants to see if it lowers CMV infections after transplant compared with the expected rate without prophylaxis.
-
Collecting blood and tissue samples for HIV/AIDS-related cancer research
This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.